Interferon alfa-2a for melanoma metastases

Lancet. 2002 Mar 16;359(9310):978-9. doi: 10.1016/S0140-6736(02)08001-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chemotherapy, Adjuvant
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Recombinant Proteins
  • Survival Analysis

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins